D-1258-2020 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1258-2020 was initiated by Akorn Inc on Mar 25, 2020 and is designated Class III. Reason for recall: Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 15,170 ampules.

Recall details

Product Type
Drugs
Report Date
Apr 8, 2020
Initiation Date
Mar 25, 2020
Termination Date
Jul 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,170 ampules

Product description

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02

Reason for recall

Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot 081887A, EXP 08/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1258-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1258-2020. Report a data issue: hello@regdatalab.com.